Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Ongoing Activation of the BCR, NFκB, and Proliferation Pathways in Mantle Cell Lymphoma: Direct in Vivo Evidence for the Role of the Lymph Node Microenvironnment

Nakhle Saba, MD, Delong Liu, PhD, Sarah E. M. Herman, PhD, Cliona Grant, MD, Kieron Dunleavy, MD, Stefania Pittaluga, Wyndham Wilson, MD PhD, Adrian Wiestner, MD PhD

Blood (2014) 124 (21): 2991.

https://doi.org/10.1182/blood.V124.21.2991.2991

Published: 2014

Journal Articles

Genome-Wide Methylation Analysis of Primary Mantle Cell Lymphomas Identifies Novel Gene Targets for Epigenetic Drug Therapy.

Violetta Leshchenko, PhD, Pei-Yu Kuo, MS, Rita Shaknovich, MD, PhD, Tobias Gellen, Yvonne Remache, BS, Marc Weniger, PhD, K. Stephen Suh, PhD, Andre Goy, MD, Wyndham Wilson, MD, PhD, Ira Braunschweig, MD, Amit Verma, MD, Adrian Wiestner, MD, PhD, Ari Melnick, MD, Samir Parekh, MD

Blood (2009) 114 (22): 673.

https://doi.org/10.1182/blood.V114.22.673.673

Published: 2009

Journal Articles

Construction and Pre-Clinical Evaluation of An Anti-CD19 Chimeric Antigen Receptor

James Kochenderfer, M.D., Steven Feldman, PhD, Yangbing Zhao, PhD, Hui Xu, Mary Black, Richard Morgan, PhD, Mark Dudley, PhD, Wyndham Wilson, MD, PhD, Steven Rosenberg, MD, PhD

Blood (2008) 112 (11): 4623.

https://doi.org/10.1182/blood.V112.11.4623.4623

Published: 2008

Journal Articles

ZAP-70 Expression Is Associated with Increased Migration to SDF-1 in Chronic Lymphocytic Leukemia.

Yuji Miura, MD, PhD, Elinor Lee, BA, Federica Gibellini, PhD, Therese White, RN, Gerald Marti, MD, Wyndham Wilson, MD/PhD, Adrian Wiestner, MD/PhD

Blood (2006) 108 (11): 587.

https://doi.org/10.1182/blood.V108.11.587.587

Published: 2006

Journal Articles

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Edgar G. Rizzatti, MD, PhD, Helena Mora-Jensen, BS, Raymond Lai, MD/PhD, Masanori Daibata, MD, Therese White, RN, Kieron Dunleavy, MD, Wyndham Wilson, MD/PhD, Adrian Wiestner, MD/PhD

Blood (2006) 108 (11): 830.

https://doi.org/10.1182/blood.V108.11.830.830

Published: 2006

Journal Articles

Potent Single Agent Activity and Tumor Selectivity of Bortezomib in Mantle Cell Lymphoma: First Impressions from a Randomized Phase II Study of EPOCH-Rituximab-Bortezomib in Untreated Mantle Cell Lymphoma.

Adrian Wiestner, MD, PhD, Kieron Dunleavy, MD, Edgar G. Rizzatti, MD/PhD, Hui Liu, Msc, Gerald E. Marti, MD, Therese White, RN, Wyndham Wilson, MD/PhD

Blood (2005) 106 (11): 4744.

https://doi.org/10.1182/blood.V106.11.4744.4744

Published: 2005

NARROW

Ongoing Activation of the BCR, NFκB, and Proliferation Pathways in Mantle Cell Lymphoma: Direct in Vivo Evidence for the Role of the Lymph Node Microenvironnment

Genome-Wide Methylation Analysis of Primary Mantle Cell Lymphomas Identifies Novel Gene Targets for Epigenetic Drug Therapy.

Construction and Pre-Clinical Evaluation of An Anti-CD19 Chimeric Antigen Receptor

ZAP-70 Expression Is Associated with Increased Migration to SDF-1 in Chronic Lymphocytic Leukemia.

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Potent Single Agent Activity and Tumor Selectivity of Bortezomib in Mantle Cell Lymphoma: First Impressions from a Randomized Phase II Study of EPOCH-Rituximab-Bortezomib in Untreated Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Ongoing Activation of the BCR, NFκB, and Proliferation Pathways in Mantle Cell Lymphoma: Direct in Vivo Evidence for the Role of the Lymph Node Microenvironnment

Genome-Wide Methylation Analysis of Primary Mantle Cell Lymphomas Identifies Novel Gene Targets for Epigenetic Drug Therapy.

Construction and Pre-Clinical Evaluation of An Anti-CD19 Chimeric Antigen Receptor

ZAP-70 Expression Is Associated with Increased Migration to SDF-1 in Chronic Lymphocytic Leukemia.

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Potent Single Agent Activity and Tumor Selectivity of Bortezomib in Mantle Cell Lymphoma: First Impressions from a Randomized Phase II Study of EPOCH-Rituximab-Bortezomib in Untreated Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only